Real Estates are the best investment for individuals.
NewLonKong
NewLonKong: New York, London, Hong Kong, For Individual Investors
Author: newlonkongCIO
AusNet (AST.AX)
AusNet (AST.AX) Services, formerly SP AusNet, is engaged in diversified energy infrastructure business. The company operates in four segments Electricity distribution, Gas distribution, Electricity transmission and Select Solutions. The electricity distribution network carries electricity from the high voltage transmission network…
RXP (RXP.AX)
RXP (RXP.AX) is a (digital) technology services company in Australia with strong growth so far.
China Distance Education (DL)
China Distance Education (DL) is the leading long-distance education network company in China. 1 ADR = 4 shares
VIPShop (VIPS)
VIPShop (VIPS) is an speciality online shop in China. 1 ADR = 5 ordinary shares.
YY (YY)
YY (YY) is China’s leading live broadcasting company with good cash flow and net income.
Tagged with: YY
Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals (REGN) is a rising star. Its sales have been growing strongly every year in the past and will do so in the future. Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for the treatment of…
Celgene (CELG)
Celgene Corporation (CELG) discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma
AMAG Pharmaceuticals (AMAG)
AMAG Pharmaceuticals, Inc., (AMAG), a specialty pharmaceutical company, provides products and services with a focus on maternal health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm…
Tagged with: AMAG
bluebird bio, Inc. (BLUE)
bluebird bio, Inc. (BLUE) is a biotech company, and it keeps losing money. Bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases.
Top
Recent Comments